ISDS Case Map
intellectual property
Civil society groups want the contents of the MoU to be made public before its finalisation to ensure that India resists US demands to influence the implementation of India's IP legislations.
India and the US have signed an agreement on intellectual property rights (IPR) ahead of US President Donald Trump’s visit. The Cabinet Wednesday approved an MoU with the US on the issue of IPRs.
A US-India trade deal will have historic significance, especially if it ushers in a period of strong collaboration to advance a shared bilateral trade agenda and effectively resolves troubles as they arise.
China agreed to extend patent terms for novel drugs "to compensate for unreasonable delays that occur in granting the patent or during pharmaceutical product marketing approvals."
This study assesses the impact of the EFTA-Mercosur free trade agreement on access to medicines, indigenous rights and women rights.
The industry is working to get US senators on record in support of including the protections it lost in NAFTA 2.0 in future trade agreements with other countries.
India's decision to pull out of RCEP means its policy on access to inexpensive drugs will not be under pressure.
Proper mandatory licenses will be exempt from claims for expropriation under the China BIT model.
Many requirements of the original USMCA have already been met by recent changes in Canadian IP legislation, but more amendments will be required to implement the USMCA.
The hard part of the trade dispute will cover long-standing issues relating to intellectual property violations and forced technology transfer by China, as well as subsidization of Chinese industries.
